Pamisell has ranked among the top searched stocks for 16 days in the past month.

As of 2:30 PM on the 29th, Pamisell is trading at 18,750 KRW, up 1.9% from the previous day. This is a 20.21% decrease compared to June 1. Pamisell is known as a bio-pharmaceutical company that developed the world’s first stem cell therapy.

Today, foreigners have a tentative net purchase of 63,963 shares. Over the past five days, individual investors have net sold 335,264 shares, while foreigners and institutions have net bought 452,141 shares and net sold 69,659 shares, respectively.

On June 22, Pamisell was a market topic for its “strength following the recommendation of Remdesivir administration.”



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing